May Measurement Month 2019: an analysis of blood pressure screening results from Poland.
Blood pressure
Control
Disease awareness
Hypertension
Screening
Treatment
Journal
European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
entrez:
12
7
2021
pubmed:
13
7
2021
medline:
13
7
2021
Statut:
epublish
Résumé
May Measurement Month 2019 is the third edition of a global initiative organized by the International Society of Hypertension aimed at raising awareness of hypertension and the need for blood pressure (BP) screening. We present data analysis from Poland. To evaluate the potential of opportunistic BP measurements as a tool for cardiovascular disease prevention programmes. To collect new country data for further annual comparisons. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in 201 sites in May 2019. BP was measured in 7072 subjects (mean age: 54 ± 15 years; 62.3% females). After multiple imputation, the age- and sex-standardized systolic BP (SBP) and diastolic BP (DBP) was 125.4/78.5 mmHg in the whole group, 133.3/82.8 mmHg in individuals on antihypertensive medication and 123.3/77.7 mmHg in those not taking antihypertensive drugs. The proportion of subjects with high BP (≥140/90 mmHg) were 41.8% in subjects taking antihypertensive drugs, and 19.6% in those not taking any antihypertensive drugs. Overall, hypertension was present in 55.4% of participants (3917 out of 7072), of whom 83.0% were aware of their diagnosis. 80.4% of hypertensives were taking antihypertensive medication. 46.7% of all hypertensives had BP controlled to target (<140/90 mmHg). Higher BP correlated with body mass index and age but not tobacco smoking. SBP but not DBP was higher in diabetic participants. These data provide evidence on the current epidemiology of hypertension and may serve as a source of information to introduce primary and secondary prevention programmes to reduce cardiovascular risk in Poland.
Identifiants
pubmed: 34248436
doi: 10.1093/eurheartj/suab045
pii: suab045
pmc: PMC8263086
doi:
Types de publication
Journal Article
Langues
eng
Pagination
B124-B127Informations de copyright
Published on behalf of the European Society of Cardiology. © The Author(s) 2021.
Références
Eur Heart J Suppl. 2020 Aug;22(Suppl H):H108-H111
pubmed: 32884486
Hypertension. 2020 Aug;76(2):333-341
pubmed: 32419505
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
Lancet Glob Health. 2018 Jul;6(7):e736-e743
pubmed: 29778399
Lancet. 2020 Oct 17;396(10258):1160-1203
pubmed: 33069325
Eur Heart J. 2019 Jul 1;40(25):2006-2017
pubmed: 31041440
Eur Heart J Suppl. 2019 Apr;21(Suppl D):D97-D100
pubmed: 31043891
Arch Med Sci. 2018 Aug;14(5):951-961
pubmed: 30154875
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326